Clinical trials
We test, we share
By providing accessible clinical trial information, we are committed to helping people - including healthcare professionals, patients and their families - improve their understanding of clinical research and its results. As part of our global transparency policy, we openly publish clinical trial outcomes. Here you can find basic information on the registration and results of our clinical trials.
Closer to patients
We strive to stay one step ahead in transforming lives. That is why we develop innovative digital applications for patients participating in our clinical studies. Through their mobile devices, patients can share progress with clinical sites, submit data, and access interactive content about their disease progression —conveniently and cost-effectively. They also have access to educational resources and healthy lifestyle tips.
Our transparency policy
Almirall is committed to the disclosure of clinical trial information in compliance t with the format and timelines requirements ofhealth authorities and the International Committee of Medical Journal Editors (ICMJE).
Clinical trials are registered prior to study initiation in public registry databases such as ClinicalTrials.gov and CTIS/EudraCT or other national registries as required, and are published in leading biomedical journals.
Summary results, including Plain Language Summaries, are reported oregistries such as ClinicalTrials.gov, the European Clinical Trials Database (EudraCT), and/or the EU CTIS. Procedures are in place to ensure that results are reported in compliance with applicable laws and regulations.
Almirall is also committed to sharing clinical trial information and data with independent researchers, patients and healthcare professionals in acccordance with internationally accepted scientific and ethical standards.
Any clinical data requests mustbe accompanied by a research protocol proposal and must (1) include a commitment to the future publication of results, (2) ensure the anonymity of patient data and (3) respect Almirall's confidential commercial information.
Our "Terms of Use" agreement must be signed before clinical data may be accessed. To facilitate data sharing in line with our Transparency Policy, researchers may submit a request by sending a
proposal here.
All requests are reviewed independently on a case-by-case basis.
Good practices in clinical trials: our standard
We carry conduct out our global clinical trials efficiently and to the highest quality standards, following internationally recognized scientific and ethical guidelines. Clinical trials are performed carried out in line accordance with regulatory requirements in each country and comply with authorities’ requirements in the countries where the trials are performed, as well as following European dDirectives and & Gguidelines, including such as Good Clinical Practices (GPC) standards from the from the International Conference Council for of Harmonization, as well as nd FDA GCP regulations lset out in Title contained in the 21 of the Code of Federal Regulations.
Medical advice
Please note that the information on this website is not intended to replace advice from healthcare professionals. Patients should always seek medical advice before starting or changing any treatment. Healthcare professionals should consult the approved labelling in the patient's country to ensure they receive the most up-to-date and appropriate information in accordance with local requirements.